Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Neoplasm of Gastrointestinal Tract”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07179692
What this trial is testing

CEA-Targeted CAR-T Therapy in CEA-Positive Advanced Solid Tumors

Who this might be right for
Lung CancerGastric CancerColon Cancer+3 more
Chongqing Precision Biotech Co., Ltd 108
Early research (Phase 1)UnknownNCT00024063
What this trial is testing

SU006668 in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerGastric Cancer+5 more
Jonsson Comprehensive Cancer Center
Not applicableStudy completedNCT02127359
What this trial is testing

Whole-Exome Sequencing (WES) of Cancer Patients

Who this might be right for
Lung AdenocarcinomaColon Adenocarcinoma
Dana-Farber Cancer Institute 244
Not applicableEnded earlyNCT04415463
What this trial is testing

Esophageal Multisegmented FCSEMS for Malignant Strictures

Who this might be right for
Oesophageal CancerEsophageal Stent Stenosis
Radboud University Medical Center 23
Not applicableLooking for participantsNCT06995898
What this trial is testing

The Vanguard Study: Testing a New Way to Screen for Cancer

Who this might be right for
Bladder CarcinomaBreast CarcinomaColorectal Carcinoma+8 more
National Cancer Institute (NCI) 24,000
Testing effectiveness (Phase 2)Ended earlyNCT04579757
What this trial is testing

Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors

Who this might be right for
Metastatic Solid TumorColorectal CancerNeuroendocrine Tumors+4 more
Hutchmed 87
Not applicableLooking for participantsNCT04981119
What this trial is testing

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Who this might be right for
Solid Tumor, AdultColorectal CancerNon Small Cell Lung Cancer+14 more
A2 Biotherapeutics Inc. 500
Early research (Phase 1)Ended earlyNCT01258868
What this trial is testing

Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural Mesotheliomas

Who this might be right for
MesoltheliomaEsophageal CancerLung Cancer+2 more
National Cancer Institute (NCI) 44
Not applicableStudy completedNCT01514214
What this trial is testing

Winged Perimeter Versus Traditional Plastic Biliary Stent for Malignant Bile Duct Obstruction

Who this might be right for
Malignant Tumor of Extrahepatic Bile Duct
University of British Columbia 58
Not applicableLooking for participantsNCT05995821
What this trial is testing

Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies

Who this might be right for
Head and Neck CancerLung CancerGastrointestinal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 1,250
Not applicableEnded earlyNCT01374100
What this trial is testing

Effect of Qigong Therapy in Patients With Advanced Lung and Gastrointestinal Cancer Undergoing Chemotherapy

Who this might be right for
Carcinoma, Non-Small-Cell LungCancer of the Gastrointestinal Tract
McGill University 52
Not applicableStudy completedNCT05113264
What this trial is testing

'Penny', a SMS Text-based Chatbot Intervention for Medication Adherence and Side Effect Management Among Patients With GI Cancers

Who this might be right for
Gastrointestinal Cancer
Abramson Cancer Center at Penn Medicine 60
Testing effectiveness (Phase 2)Ended earlyNCT02711137
What this trial is testing

Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies

Who this might be right for
Solid Tumors
Incyte Corporation 137
Testing effectiveness (Phase 2)Study completedNCT00002475
What this trial is testing

Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerColorectal CancerKidney Cancer+3 more
St. Vincent Medical Center - Los Angeles 40
Not applicableStudy completedNCT01160367
What this trial is testing

Trial of Ascertaining Individual Preferences for Loved One's Role in End-of-Life

Who this might be right for
Amyotrophic Lateral SclerosisGI CancerPancreatic Cancer
Johns Hopkins University 431
Testing effectiveness (Phase 2)WithdrawnNCT05582031
What this trial is testing

Regorafenib With Tislelizumab in Patients With Selected Mismatch Repair-Proficient/Microsatellite Stable Cancers

Who this might be right for
Anal Squamous Cell CarcinomaColorectal NeoplasmsSoft Tissue Sarcoma+5 more
Translational Research in Oncology
Not applicableStudy completedNCT04736472
What this trial is testing

Implementing Pharmacogenetic Testing in Gastrointestinal Cancers

Who this might be right for
Gastrointestinal Cancer
Abramson Cancer Center at Penn Medicine 552
Large-scale testing (Phase 3)Study completedNCT00680901
What this trial is testing

LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib

Who this might be right for
Neoplasms, Gastrointestinal Tract
Novartis Pharmaceuticals 545
Early research (Phase 1)Study completedNCT00514007
What this trial is testing

Study of Continuous OSI-906 Dosing

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Inc 95
Testing effectiveness (Phase 2)Looking for participantsNCT06885034
What this trial is testing

Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)

Who this might be right for
Gastrointestinal Neoplasms
GlaxoSmithKline 451
Next Page